1. Home
  2. PPBT vs OBLG Comparison

PPBT vs OBLG Comparison

Compare PPBT & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • OBLG
  • Stock Information
  • Founded
  • PPBT 2010
  • OBLG 2000
  • Country
  • PPBT Israel
  • OBLG United States
  • Employees
  • PPBT N/A
  • OBLG N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • PPBT Health Care
  • OBLG Technology
  • Exchange
  • PPBT Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • PPBT 6.2M
  • OBLG 5.5M
  • IPO Year
  • PPBT N/A
  • OBLG N/A
  • Fundamental
  • Price
  • PPBT $2.33
  • OBLG $4.16
  • Analyst Decision
  • PPBT Strong Buy
  • OBLG
  • Analyst Count
  • PPBT 1
  • OBLG 0
  • Target Price
  • PPBT $33.00
  • OBLG N/A
  • AVG Volume (30 Days)
  • PPBT 251.5K
  • OBLG 140.0K
  • Earning Date
  • PPBT 08-15-2025
  • OBLG 08-06-2025
  • Dividend Yield
  • PPBT N/A
  • OBLG N/A
  • EPS Growth
  • PPBT N/A
  • OBLG N/A
  • EPS
  • PPBT N/A
  • OBLG N/A
  • Revenue
  • PPBT N/A
  • OBLG $2,374,000.00
  • Revenue This Year
  • PPBT N/A
  • OBLG N/A
  • Revenue Next Year
  • PPBT N/A
  • OBLG N/A
  • P/E Ratio
  • PPBT N/A
  • OBLG N/A
  • Revenue Growth
  • PPBT N/A
  • OBLG N/A
  • 52 Week Low
  • PPBT $2.00
  • OBLG $1.91
  • 52 Week High
  • PPBT $13.95
  • OBLG $7.20
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 40.95
  • OBLG 46.49
  • Support Level
  • PPBT $2.35
  • OBLG $4.57
  • Resistance Level
  • PPBT $2.90
  • OBLG $5.50
  • Average True Range (ATR)
  • PPBT 0.17
  • OBLG 0.60
  • MACD
  • PPBT 0.00
  • OBLG -0.08
  • Stochastic Oscillator
  • PPBT 13.29
  • OBLG 21.18

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: